Objective: To compare the performance and accuracy of the JM-103 transcutaneous bilirubinometer and Bilistick System in measuring total serum bilirubin for the early identification of neonatal hyperbilirubinemia.
Study Design: The study was performed on 126 consecutive term and near-term (⩾36 weeks' gestational age) jaundiced newborns in Cairo University Children Hospital NICU, Egypt. Total serum bilirubin was assayed concurrently by the clinical laboratory and Bilistick System and estimated using the JM-103 transcutaneous bilirubin instrument. Bland-Altman analysis was used to evaluate the agreement between determinations.
Result: The limits of agreement of the Bilistick System (-5.8 to 3.3 mg dl) and JM-103 system (-5.4 to 6.0 mg dl) versus the clinical laboratory results were similar.
Conclusion: The Bilistick System is an accurate alternative to transcutaneous (TcB) determination for early diagnosis and proper management of the neonatal jaundice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/jp.2017.94 | DOI Listing |
Neonatology
March 2022
Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.
Background: Recently, the Bilistick®, a point-of-care instrument to measure bilirubin levels, has been developed. It is fast and cheaper than transcutaneous bilirubin (TCB)-measuring devices, but data on diagnostic properties are scarce.
Objective: This study aimed to compare the performance of the Bilistick® (BM-BS 1.
Pediatr Res
August 2021
Italian Liver Foundation, Trieste, Italy.
Invasive bilirubin measurements remain the gold standard for the diagnosis and treatment of infants with severe neonatal hyperbilirubinemia. The present paper describes different methods currently available to assess hyperbilirubinemia in newborn infants. Novel point-of-care bilirubin measurement methods, such as the BiliSpec and the Bilistick, would benefit many newborn infants, especially in low-income and middle-income countries where the access to costly multi-analyzer in vitro diagnostic instruments is limited.
View Article and Find Full Text PDFJ Trop Pediatr
December 2020
Department of Neonatology, Fernandez Hospital, Hyderabad, Telangana 500029, India.
Introduction: Early diagnosis and appropriate management of neonatal jaundice is crucial in avoiding severe hyperbilirubinemia and brain injury. A low-cost, minimally invasive, point-of-care (PoC) tool for total bilirubin (TB) estimation which can be useful across all ranges of bilirubin values and all settings is the need of the hour.
Objective: To assess the accuracy of Bilistick system, a PoC device, for measurement of TB in comparison with estimation by spectrophotometry.
EClinicalMedicine
July 2018
Bilimetrix s.r.l., Area Science Park, 34149 Trieste, Italy.
Importance: The real prevalence and clinical burden of severe neonatal jaundice are undefined due to difficulties in measuring total serum bilirubin (TSB) outside secondary and tertiary clinical centers.
Objective: To assess the diagnostic performance of the point-of care Bilistick System (BS) in identifying neonatal jaundice patients requiring treatment.
Design: Between April 2015 and November 2016, 1911 neonates, were recruited to participate in the study.
Pediatr Res
August 2019
Division of Neonatology, Careggi University Hospital of Florence, Florence, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!